ABPI position on mandatory disclosure of clinical data
This article was originally published in Scrip
Scrip asked the UK industry association, the ABPI, if it would support legislation to make it universally obligatory to publish clinical study reports, both new and old, relating to currently available drugs and to those that are in development or have been discontinued. Scrip also asked if ABPI could identify potential problems with such legislation, and propose ideas for avoiding or overcoming them.
Register for our free email digests: